Abstract

ObjectiveThis meta-analysis was performed to evaluate the role of toll-like receptor 4 (TLR-4) in colorectal carcinogenesis.MethodsThe PubMed, CISCOM, CINAHL, Web of Science, Google Scholar, EBSCO, Cochrane Library, and CBM databases were searched from inception through November 1st, 2013 without language restrictions. Odds ratios (ORs) or standardized mean differences (SMD) with their 95% confidence intervals (CI) were calculated.ResultsFourteen case-control studies met the inclusion criteria for this meta-analysis. A total of 1,209 colorectal cancer (CRC) cases and 1,218 healthy controls were involved in this meta-analysis. Two common polymorphisms (299 A>G and 399 C>T) in the TLR-4 gene, TLR-4 mRNA and protein expression were assessed. Our meta-analysis results revealed that the TLR-4 399 C>T polymorphism might increase the risk of CRC (allele model: OR = 1.77, 95%CI = 1.32∼2.36, P<0.001; dominant model: OR = 1.83, 95%CI = 1.32∼2.52, P<0.001; respectively). However, we found no correlation between the TLR-4 299 A>G polymorphism and CRC risk (all P>0.05). A subgroup analysis by ethnicity suggested that TLR-4 genetic polymorphisms were associated with an increased risk of CRC among Asians (allele model: OR = 1.50, 95%CI = 1.19∼1.88, P = 0.001; dominant model: OR = 1.49, 95%CI = 1.16∼1.92, P = 0.002; respectively), but not among Caucasians and Africans (all P>0.05). Furthermore, our results showed that TLR-4 mRNA and protein levels in CRC patients were higher than those in healthy controls (TLR-4 mRNA: SMD = 2.51, 95%CI = 0.98∼4.05, P = 0.001; TLR-4 protein: OR = 4.75, 95%CI = 1.16∼19.36, P = 0.030; respectively).ConclusionOur findings provide empirical evidence that TLR-4 may play an important role in colorectal carcinogenesis. Thus, TLR-4 is a promising potential biomarker for the early diagnosis of CRC.

Highlights

  • Colorectal cancer (CRC), which includes colon and rectal cancers, is the third most commonly diagnosed cancer in males and the second in females [1,2]

  • toll-like receptor 4 (TLR-4) belongs to a family of Toll-like receptors (TLRs), which are receptors playing the main role in the recognition of a wide array of pathogens, including viruses, bacteria, protozoa, and fungi [8]

  • Our findings suggested that genetic polymorphisms in TLR-4 genes were associated with an increased risk of CRC among Asian populations, but not among Caucasian

Read more

Summary

Introduction

Colorectal cancer (CRC), which includes colon and rectal cancers, is the third most commonly diagnosed cancer in males and the second in females [1,2]. The symptoms of CRC typically include rectal bleeding and anemia, which are sometimes associated with weight loss and changes in bowel habits [3]. It has been recognized that colorectal cancer is a multifactorial disease caused by complex interactions between environmental and genetic factors [4]. Many candidate genes have been identified, such as toll-like receptor 4 (TLR-4), which may be implicated in the genesis of colorectal cancer [6,7]. TLR-4 belongs to a family of Toll-like receptors (TLRs), which are receptors playing the main role in the recognition of a wide array of pathogens, including viruses, bacteria, protozoa, and fungi [8]. The human TLR-4 gene is located in chromosomal region 9

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call